CLINICAL TRIALS PROFILE FOR PYRVINIUM PAMOATE
✉ Email this page to a colleague
All Clinical Trials for pyrvinium pamoate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05055323 ↗ | A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer | Recruiting | Thomas Jefferson University | Phase 1 | 2021-07-29 | This phase I trial studies the side effects and best dose of pyrvinium pamoate for the treatment of pancreatic ductal adenocarcinoma that cannot be removed by surgery (resectable). Pyrvinium pamoate may slow down tumor growth and help patients live longer. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for pyrvinium pamoate
Condition Name
Clinical Trial Locations for pyrvinium pamoate
Trials by Country
Clinical Trial Progress for pyrvinium pamoate
Clinical Trial Phase
Clinical Trial Sponsors for pyrvinium pamoate
Sponsor Name